Author: McLeod, Robbie L.; Angagaw, Minilik H.; Baral, Toya Nath; Liu, Liming; Moniz, Raymond Joseph; Laskey, Jason; Hsieh, SuChun; Lee, Mike; Han, Jin-Hwan; Issafras, Hassan; Javaid, Sarah; Loboda, Andrey; Sadekova, Svetlana; O'Connor, Joann A.; Tse, Archie; Punnonen, Juha
Title: Characterization of murine CEACAM1 in vivo reveals low expression on CD8(+) T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1 Document date: 2018_10_2
ID: 01id7jq6_7
Snippet: To delineate a potential mechanism of CEACAM-1 blockade for anti-tumor therapy, the expression profile of surface CEACAM-1 in tumor infiltrates was comprehensively assessed using flow cytometry. Several mouse syngeneic tumor models, MBT2, MC38, CT26, and MB49, were used for the analyses to avoid a tumor type-specific bias. About 100 mm 3 of subcutaneous tumors were established 7-10 days post implant. The CEACAM1 expression was first measured from.....
Document: To delineate a potential mechanism of CEACAM-1 blockade for anti-tumor therapy, the expression profile of surface CEACAM-1 in tumor infiltrates was comprehensively assessed using flow cytometry. Several mouse syngeneic tumor models, MBT2, MC38, CT26, and MB49, were used for the analyses to avoid a tumor type-specific bias. About 100 mm 3 of subcutaneous tumors were established 7-10 days post implant. The CEACAM1 expression was first measured from untreated tumors by flow cytometry ( Figure 1A ). In all cases, high level of CEACAM1 expression was observed on granulocytic (CD11b+ Ly6G+ Ly6Clow) and monocytic (CD11b+ Ly6G− Ly6C+) myeloid cells from all tumors tested ( Figure 1A , MB49 not shown). The frequency of CEACAM1-expressing CD4+ or CD8+ T cells and the expression level of CEACAM1 on these cells were low.
Search related documents:
Co phrase search for related documents- expression profile and high level: 1, 2, 3, 4, 5, 6, 7, 8
- flow cytometry and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- flow cytometry and mouse syngeneic: 1
- flow cytometry and myeloid cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- flow cytometry and potential mechanism: 1, 2, 3, 4, 5, 6, 7
- flow cytometry and subcutaneous tumor: 1, 2
- flow cytometry and tumor model: 1, 2, 3, 4, 5
- flow cytometry assess and potential mechanism: 1
- high level and myeloid cell: 1
- high level and potential mechanism: 1, 2, 3, 4, 5, 6, 7
- high level and tumor model: 1, 2, 3
- mouse syngeneic and subcutaneous tumor: 1
- mouse syngeneic and tumor model: 1, 2
- mouse syngeneic tumor model and tumor model: 1
- myeloid cell and potential mechanism: 1, 2
- myeloid cell and tumor model: 1
- potential mechanism and tumor infiltrate: 1
- subcutaneous tumor and tumor model: 1, 2, 3, 4, 5, 6, 7
- subcutaneous tumor and untreated tumor: 1
Co phrase search for related documents, hyperlinks ordered by date